Almac Almac NGS-Based CDx Gets CE Mark Almac said that the assay will be used in a clinical study of repotrectinib (TPX-0005), an investigational, next-generation tyrosine kinase inhibitor. Almac Assay's Ability to Stratify Esophageal Cancer Patients Demonstrated by UK Researchers Premium The test relies on a signature that Almac developed for stratifying breast cancer patients, but which, as the researchers showed, can be used in other cancers as well. FDA Grants IDE Approval for Almac Diagnostic Services' CDx for Use in Cancer Drug Study The next-generation sequencing assay is intended for use in identifying patients with ROS1, NTRK1-3, and ALK gene fusions in advanced solid tumors. Almac Developing Next-Generation Sequencing Assay for TP Therapeutics' Anti-Tumor Therapy Premium Almac is developing the assay to enroll patients for clinical trials used to develop repotrectinib, an investigational tyrosine kinase inhibitor. Almac Diagnostic Services to Build Pan-Cancer NGS Companion Test for TP Therapeutics The test is intended to identify patients with ROS1, NTRK, and ALK gene fusions for treatment with TP's investigational drug repotrectinib. Apr 25, 2017 Almac Dx Develops Prostate Cancer Assay to Detect Risk of Metastatic Recurrence Premium Mar 8, 2017 Almac Diagnostics, EORTC Collaborate to Establish Molecular Profiles for Cancer Patients Oct 7, 2016 In Brief This Week: Foundation Medicine; Exact Sciences; Eurofins Genomics; and More Dec 15, 2015 Almac, Analytics to Use Innovate UK Grant to Improve Bioinformatics for Biomarker Discovery Premium Nov 12, 2015 Illumina, Almac to Collaborate on NGS CDx Assays Jun 22, 2015 Almac, OncoMed to Develop CDx for R-Spondin 3 Jul 1, 2014 Almac Diagnostics Sees 'Significant' Pharma Interest in Cancer Subgroup Typing Test Premium Jun 10, 2014 Almac's Ovarian Cancer Patient Stratification Test Could Be Used to Select Treatment for Other Diseases Premium Apr 15, 2014 Almac Diagnostics Business Receives Clinical Lab Permit from New York Jan 28, 2014 Precision Therapeutics, Partners Validate Almac's ColDx Colorectal Cancer Test ahead of US Launch Premium Jan 21, 2014 Almac's Disease Specific Array Yields Multi-gene Breast Cancer Chemotherapy Response Test Premium May 15, 2013 Almac, UCL Co-developing Metagenomics, Enzyme Discovery Tools Feb 22, 2013 In Brief This Week: Luminex; Life Technologies; CombiMatrix; Danaher; Biotrial, Warnex; Almac Aug 24, 2012 In Brief This Week: Almac Diagnostics; Leica, Aperio; GenScript; University of Nebraska Aug 22, 2012 New Products: LifeCodexx's PraenaTest; Almac's Sequencing Services Premium Apr 3, 2012 Affymetrix to Distribute Almac's Xcel Array for Biomarker Discovery Premium Feb 3, 2012 Almac Expands Bioinformatics Offering to Include Sequence Data Analysis Services Premium Jan 17, 2012 People in the News: Kevin Stevens Premium Jan 13, 2012 People in the News: Jan 13, 2012 Nov 30, 2011 Almac Diagnostics UK Facility Gets CAP Accreditation Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.